BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19333554)

  • 1. 'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors.
    Thomas R; Duke SE; Wang HJ; Breen TE; Higgins RJ; Linder KE; Ellis P; Langford CF; Dickinson PJ; Olby NJ; Breen M
    J Neurooncol; 2009 Sep; 94(3):333-49. PubMed ID: 19333554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNA copy number landscape of a collision tumor.
    Kearney H; Cryan JB; Looby S; Brett FM; Farrell MA; Buckley PG
    Clin Neuropathol; 2018; 37(2):68-73. PubMed ID: 29350171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
    Hedan B; Thomas R; Motsinger-Reif A; Abadie J; Andre C; Cullen J; Breen M
    BMC Cancer; 2011 May; 11():201. PubMed ID: 21615919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.
    Dickinson PJ; York D; Higgins RJ; LeCouteur RA; Joshi N; Bannasch D
    J Neuropathol Exp Neurol; 2016 Jul; 75(7):700-10. PubMed ID: 27251041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions on chromosome 22 in sporadic meningioma.
    Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
    Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
    J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray.
    Wada K; Maruno M; Suzuki T; Kagawa N; Hashiba T; Fujimoto Y; Hashimoto N; Izumoto S; Yoshimine T
    Neurol Res; 2005 Oct; 27(7):747-54. PubMed ID: 16197812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meningioma: a model of cytogenetic evolution in tumoral initiation and progresion].
    López-Ginés C; Gil-Benso R; Collado-Díaz M; Gregori-Romero M; Roldán P; Barberá J; Cerdá-Nicolás M
    Neurocirugia (Astur); 2003 Dec; 14(6):517-25. PubMed ID: 14710307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.
    Roode SC; Rotroff D; Avery AC; Suter SE; Bienzle D; Schiffman JD; Motsinger-Reif A; Breen M
    Chromosome Res; 2015 Dec; 23(4):681-708. PubMed ID: 26037708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
    Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
    Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.
    Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O
    Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic loss at 1p is associated with tumor progression of meningiomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.